Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: Role of 5-HT3 receptors

Journal of Neuroscience

Volumn 18, Issue 16, 1998, Pages 6528-6538

  De Deurwaerdère, Philippe ^a   Stinus, Luis ^b   Spampinato, Umberto ^a  

^a INSERM   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

5,7 dihydroxytryptamine; Dopamine release; Dorsal raphe nucleus; Electrical stimulation; Halothane anesthetized rat; Microdialysis; Nucleus accumbens; Parachlorophenylalanine; Serotonin; Striatum

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DORSAL RAPHE NUCLEUS; ELECTROSTIMULATION; MALE; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT;

EID: 17344362092     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.18-16-06528.1998     Document Type: Article

References (33)

1. Andersen E, Rigor B, Dafny N (1983) Electrophysiological evidence of concurrent dorsal raphe input to caudate, septum, habenula, thalamus, hippocampus, cerebellum, and olfactory bulb. Int J Neurosci 18:107-116.
2. Ashby Jr CR, Wang RY (1996) Pharmacological actions of the typical antipsychotic drug clozapine: a review. Synapse 24:349-394.
3. Azmitia EC, Segal M (1978) An autoradiographic study of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179:641-668.
4. 3H]-(S)-zacopride in the forebrain of the rat. Neuropharmacology 29:1037-1045.
5. Baumgarten HC, Bjorklund A, Lackenmayer L, Nobin A (1973) Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurones in the rat CNS. Acta Physiol Scand 391:1-19.
6. Benloucif S, Galloway MP (1991) Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. Eur J Pharmacol 200:1-8.
7. Blandina P, Goldfarb J, Craddock-Royal B, Green JP (1989) Release of endogenous dopamine by stimulation of 5-hydroxytryptamine receptors in rat striatum. J Pharmacol Exp Ther 251:803-809.
8. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rats. Neuropharmacology 34:269-279.
9. 3 receptor antagonists block morphine- and nicotine- but not amphetamineinduced reward. Psychopharmacology 97:175-178.
10. 3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol 164:515-519.
11. 3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens. Pharmacol Biochem Behav 55:33-37.
12. 3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens. Brain Res 543:354-357.
13. Compan V, Dusticier N, Nioullon A, Daszuta A (1996) Opposite changes on striatal neuropeptide Y after immunoreactivity after partial and complete serotonergic depletion in the rat. Synapse 24:87-96.
14. 3 receptor antagonist, GR38032F, on raised dopaminergic activity system of the rat and marmoset brain. Br J Pharmacol 92:881-894.
15. Cudennec A, Duverger D, Serrano A, Scatton B, McKenzie ET (1988) Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphe nuclei. Brain Res 444:227-246.
16. De Deurwaerdère P, Bonhomme N, Le Moal M, Spampinato U (1995) D-Fenfluramine increases striatal extracellular dopamine in vivo independently of serotonergic terminals or dopamine uptake sites. J Neurochem 65:1100-1108.
17. De Simoni M, Giglio R, Dal Toso G, Kostowski W, Algeri S (1985) Interaction between serotonergic and dopaminergic systems detected in striatum by differential pulse voltammetry. Eur J Pharmacol 111:289-290.
18. De Simoni MG, Dal Toso G, Froditto F, Sokola A, Algeri S (1987) Modulation of striatal metabolism by the activity of dorsal raphe serotonergic afferences. Brain Res 411:81-88.
19. Deutch AY, Moghaddam B, Innis RB, Krystal JH, Aghajanian GK, Bunney BS, Charney DS (1991) Mechanisms of action of atypical antipsychotic drugs. Implication for novel therapeutic strategies for schizophrenia. Schizophr Res 4:121-156.
20. Fontana DJ, Daniels SE, Eglen RM, Wong EHF (1996) Stereoselective effects of (R)- and (S)-zacopride on cognitive performance in a spatial navigation task in rats. Neuropharmacology 35:321-327.
21. 3 receptor antagonists on the morphine-induced excitation of A10 dopamine cells: electrophysiological studies. Brain Res 638:325-328.
22. 3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol Sei 14:265-270.
23. Guan XM, McBride WJ (1989) Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release. Brain Res Bull 23:541-547.
24. 3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the tegmental area of the rat brain. Eur J Pharmacol 138:303-305.
25. Hicks PB (1990) The effect of serotoninergic agents on haloperidol-induced catalepsy. Life Sci 47:1609-1615.
26. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203.
27. 3 antagonists reduce morphine self-administration in rats. Br J Pharmacol 110:1341-1346.
28. 3 receptors control dopamine release in the nucleus accumbens of freely moving rats. Neurosci Lett 101:214-217.
29. James TA, Starr MS (1980) Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. J Pharm Pharmacol 32:196-200.
30. 3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study. Brain Res 513:156-160.
31. Kapur S, Remington G (1996) Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153:466-476.
32. Kelland MD, Freeman AS, Chiodo LA (1990) Serotonergic afferent regulation of the basic physiology and pharmacological responsiveness of nigrostriatal dopamine neurons. J Pharmacol Exp Ther 253:803-811.
33. Kelland MD, Freeman AS, Rubin J, Chiodo LA (1993) Ascending afferent regulation of rat midbrain dopamine neurons. Brain Res Bull 31:539-546.